MCAC To Weigh Emerging Treatments For Age-Related Macular Degeneration
This article was originally published in The Gray Sheet
Executive Summary
CMS' Medicare Coverage Advisory Committee will convene Nov. 29 in Baltimore to evaluate the evidence for age-related macular degeneration (AMD) treatments